JAIME A SUAREZ LONDONO

Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology NEW YORK, NY NPI 1457791691

General Payments — all program years on this page

$48,735.50

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 59
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $7,308.49 across 6 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
SANOFI-AVENTIS U.S. LLC $3,291.782
SERVIER PHARMACEUTICALS LLC $1,960.001
Acerta Pharma LLC $1,942.501
Siemens Medical Solutions USA, Inc. $114.212

By program year

Program yearAmountRecords
2018 $6,097.6813
2019 $11,589.9719
2020 $8,756.0710
2021 $3,129.503
2022 $7,748.364
2023 $4,105.434
2024 $7,308.496

Records — PY2024 (6)

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.